City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
October 9, 2017 | Deborah Stambler
For all the things AML took away, it also gave Jim Alder a voice. His job now, he says, is to educate others on how easy it is to become a donor.
July 3, 2017 | Letisia Marquez
Lester Wakefield has told police officer Jonathan Bottom, the young man who donated bone marrow stem cells to the 69-year-old Wakefield, that he is thankful for his lifesaving donation. He's told him many, many times. And still Wakefield feels he hasn’t thanked Bottom enough.
May 12, 2017 | Samantha Bonar
Nine months after her daughter’s birth, Monica Weld got a bad sore throat and cough that she just couldn’t shake. She and her husband went directly to the hospital, where tests showed she had not one, but two kinds of leukemia: acute lymphoblastic (ALL) and acute myeloid (AML).
December 20, 2016 | Samantha Bonar
TNT's veteran NBA courtside reporter Craig Sager, known as much for his flamboyant suits as his sideline interviews, died on December 15 after a two-year battle with acute myeloid leukemia.
December 15, 2015 | Elise Lamar
Older patients with acute myelogenous leukemia may ultimately have a drug that, if not made just for them, at least better meets their needs.
April 1, 2015 | Nicole White
Acute myeloid leukemia is the most common form of acute leukemia among adults, accounting for 18,000 diagnoses in 2014. Two decades after the first ever clinical practice guidelines were published, AML treatments have come a long way.
November 11, 2014 | Dominique Grignetti
In February 2003, when she was only 16 months old, Maya Gallardo was diagnosed with acute myelogenous leukemia (AML) and, to make matters much worse, pneumonia. Aaron Gallardo hugs his little sister Maya, while she was sick with acute myelogenous leukemia.
July 18, 2014 | Darrin Joy
Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia , or AML. In a new treatment for acute myeloid leukemia, Elizabeth Budde is using modified white blood cells to attack their malignant cousins.
May 3, 2014 | Kim Proescholdt
Editor's Update: Ravi Bhatia has since left City of Hope. He joined the University of Alabama at Birmingham in January 2015. City of Hope Every four minutes, someone is diagnosed with a blood cancer. More than 156,000 new cases in the U.
Load MoreBack To Top